This is a guest contribution from Meredith Barranco, PhD, at the New York State Department of Health’s Office of Hepatitis Health Care and Epidemiology. Hepatitis C and HIV are both chronic blood-borne viral infections that impact New Yorkers. As “syndemic” conditions, they tend to cluster within specific populations and interact with social and structural factors that can […]
Tag Archives: Blog
24
Aug
Aug
Hepatitis C remains one of the most commonly reported blood-borne infections in the United States and continues to cause significant morbidity and mortality when undiagnosed or untreated. Nationally, hepatitis C infection disproportionately affects individuals in correctional settings, with a rate approximately 10 times higher as compared to the general population[1]. The New York State Hepatitis […]
30
Jul
Jul
People who use drugs (PWUD) are at the highest risk for acquiring hepatitis C. The New York State (NYS) Hepatitis C Elimination plan has identified PWUD as the priority population for elimination. New treatments available to cure hepatitis C should be made accessible to PWUD. Guidelines support treating PWUD, even those actively using. As shown […]
07
May
May
Newly released hepatitis C (HCV) elimination metrics show that in 2024, 4,323 people were newly diagnosed with HCV in New York State (NYS), a 9.7% decrease from 2023 and a 75.7% decrease overall since 2014. From 2010 to 2024, 203,442 New Yorkers were diagnosed with HCV, of which 55.9% are known to have cleared their […]
21
Jan
Jan
Click to view full page flyer Sign up here
29
Oct
Oct
In June of 2024, the United States (US) Food and Drug Administration (FDA) approved Cepheid’s GeneXpert (XpertⓇHCV) for Point of Care (POC) hepatitis C (HCV) diagnostic testing, the first of its kind for HCV in the US. The test is CLIA (Clinical Laboratory Improvement Amendment) waived, meaning the instrument is simple to use and with […]
06
Jun
Jun
On May 15, 2024, New York State hosted the second Annual Hepatitis C Elimination Progress Report virtual meeting to share progress toward reaching its elimination goals, as outlined in the 2021 release of the New York State Hepatitis C Elimination Plan. All of the materials and presentations from the May meeting are now available: Hepatitis […]
Announcements
Newly Released 2022 New York State Hepatitis C Elimination Metrics Data is Now Available
15
May
May
In 2022 there were 5,169 people newly diagnosed with hepatitis C (HCV) in New York State (NYS), a 9% decrease from 2021, continuing the downward trend of HCV diagnoses over the previous decade. Between 2010 and 2022, 194,375 New Yorkers were diagnosed with HCV, and of those, 53% are known to have cleared their infection […]
15
Feb
Feb
NYS Test4HepC Campaign to Promote Hepatitis C Screening During Pregnancy Universal hepatitis C screening among pregnant people was identified in the New York State Hepatitis C Elimination Plan as a priority for moving the state towards hepatitis C elimination by 2030. Effective May 3, 2024, New York State’s hepatitis C testing legislation will require all […]
- 1
- 2